Metraipolis › archive › dc_bb1c92b0932b
CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges — Europe PMC PMID:42199538
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42199538
- DOI
- 10.3389/fmicb.2026.1747931
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T11:29:56.182Z
- SHA-256 of the archived text
0933cca17532e41103bc58bd9e80d8687baf52250d95d1402efc040c0cbf0a6c- Stable URL of this page
https://metraipolis.com/documento/dc_bb1c92b0932b
How to cite
CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges — Europe PMC PMID:42199538 — Europe PMC (en), https://europepmc.org/article/MED/42199538 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb1c92b0932b (Metraipolis archive dc_bb1c92b0932b, sha256 0933cca17532e41103bc58bd9e80d8687baf52250d95d1402efc040c0cbf0a6c)
BibTeX
@misc{dcbb1c92b0932b,
title = {CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges — Europe PMC PMID:42199538},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42199538},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb1c92b0932b; sha256 0933cca17532e41103bc58bd9e80d8687baf52250d95d1402efc040c0cbf0a6c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42199538. Agents can read the archived copy with the MCP tool read_document.